{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:10Z","timestamp":1791639550316,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015769","name":"Dexcom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK111024"],"award-info":[{"award-number":["P30DK111024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K23DK123384"],"award-info":[{"award-number":["1K23DK123384"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R03DK138255"],"award-info":[{"award-number":["1R03DK138255"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eprac.2025.05.749","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:48:43Z","timestamp":1749066523000},"page":"1046-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-9603","authenticated-orcid":false,"given":"Shubham","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Savian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia C.","family":"Low Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_1","key":"10.1016\/j.eprac.2025.05.749_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.749_bib2","doi-asserted-by":"crossref","DOI":"10.2337\/dci21-0035","article-title":"Hemoglobin A1c-using epidemiology to guide medical practice: kelly west award lecture 2020","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.749_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108502","article-title":"Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology","volume":"170","author":"Galindo","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/193229681300700234","article-title":"Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile","volume":"7","author":"Bergenstal","year":"2013","journal-title":"J Diabetes Sci Technol"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2025.05.749_bib5","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes technology: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diabres.2008.06.015","article-title":"Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes","volume":"82","author":"Yoo","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/dom.14949","article-title":"IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): a randomized controlled trial","volume":"25","author":"Aronson","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001115","article-title":"Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial","volume":"8","author":"Wada","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc18-0166","article-title":"Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes","volume":"42","author":"Yaron","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.05.749_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109172","article-title":"The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: a prospective observational cohort study","volume":"183","author":"Bosi","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(19)30385-7","article-title":"Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial","volume":"8","author":"Furler","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib20","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s13300-021-01086-y","article-title":"Episodic real-time CGM use in adults with type 2 diabetes: results of a pilot randomized controlled trial","volume":"12","author":"Price","year":"2021","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/dom.14852","article-title":"Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type 2 diabetes: a randomized controlled trial","volume":"25","author":"Moon","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc11-1438","article-title":"Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes","volume":"35","author":"Vigersky","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib15","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2337\/dc12-1225","article-title":"Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application","volume":"36","author":"Fonda","year":"2013","journal-title":"Diabetes Care"},{"issue":"22","key":"10.1016\/j.eprac.2025.05.749_bib16","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.749_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.108106","article-title":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","volume":"36","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Complications"},{"issue":"12","key":"10.1016\/j.eprac.2025.05.749_bib19","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2337\/dc21-1304","article-title":"The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin","volume":"44","author":"Aleppo","year":"2021","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2025.05.749_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/ndt\/gfu006","article-title":"Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?","volume":"29","author":"Speeckaert","year":"2014","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107707","article-title":"Diabetes mellitus in chronic kidney disease: biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality","volume":"34","author":"Copur","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib23","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1210\/jc.2019-00286","article-title":"Disturbances in insulin-glucose metabolism in patients with advanced renal disease with and without diabetes","volume":"104","author":"Rahhal","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.749_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic monitoring and management in advanced chronic kidney disease","volume":"41","author":"Galindo","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eprac.2025.05.749_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/193229680900300446","article-title":"Glucose meters: a review of technical challenges to obtaining accurate results","volume":"3","author":"Tonyushkina","year":"2009","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/dia.2007.0257","article-title":"Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters","volume":"10","author":"Karon","year":"2008","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/dc06-1679","article-title":"Glucose measurement: confounding issues in setting targets for inpatient management","volume":"30","author":"Dungan","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1542-4758.2011.00640.x","article-title":"Endogenous factors modified by hemodialysis may interfere with the accuracy of blood glucose-measuring device","volume":"16","author":"Ogawa","year":"2012","journal-title":"Hemodial Int"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.749_bib29","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00125-024-06244-y","article-title":"Diabetes technology in people with diabetes and advanced chronic kidney disease","volume":"67","author":"Galindo","year":"2024","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/19322968241292041","article-title":"Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes","volume":"19","author":"Rhee","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/dia.2023.0013","article-title":"The accuracy of continuous glucose sensors in people with diabetes undergoing hemodialysis (ALPHA study)","volume":"25","author":"Avari","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/1932296819882690","article-title":"Comparison of interstitial fluid glucose levels obtained by continuous glucose monitoring and flash glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"14","author":"Yajima","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107680","article-title":"Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"34","author":"Matoba","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000362863","article-title":"Glycemic pattern in diabetic patients on hemodialysis: continuous glucose monitoring (CGM) analysis","volume":"38","author":"Gai","year":"2014","journal-title":"Blood Purif"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.749_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","article-title":"Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study","volume":"107","author":"Joubert","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.749_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dia.2010.0052","article-title":"Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis","volume":"12","author":"Mirani","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.749_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/dia.2010.0067","article-title":"Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system","volume":"12","author":"Jung","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/dc08-1688","article-title":"Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes","volume":"32","author":"Kazempour-Ardebili","year":"2009","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1055\/s-0034-1370963","article-title":"Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring","volume":"46","author":"Chantrel","year":"2014","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5414\/CN108280","article-title":"Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study","volume":"82","author":"K\u00e9p\u00e9n\u00e9kian","year":"2014","journal-title":"Clin Nephrol"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/dia.2024.0145","article-title":"Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis","volume":"26","author":"Galindo","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2337\/dci23-0086","article-title":"The glucose management indicator: time to change course?","volume":"47","author":"Selvin","year":"2024","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib43","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1681\/ASN.2017080828","article-title":"Mechanisms of crystalloid versus colloid osmosis across the peritoneal membrane","volume":"29","author":"Morelle","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8552","key":"10.1016\/j.eprac.2025.05.749_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(87)90764-1","article-title":"Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges","volume":"2","author":"Mistry","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.749_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057762","article-title":"Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"issue":"1-3","key":"10.1016\/j.eprac.2025.05.749_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000439242","article-title":"Use of continuous glucose monitoring in patients with diabetes mellitus on peritoneal dialysis: correlation with glycated hemoglobin and detection of high incidence of unaware hypoglycemia","volume":"41","author":"Qayyum","year":"2016","journal-title":"Blood Purif"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2337\/dc22-2348","article-title":"Evaluation of a fourth-generation subcutaneous real-time continuous glucose monitor (CGM) in individuals with diabetes on peritoneal dialysis","volume":"46","author":"Ng","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/dia.2023.0349","article-title":"Impact of body composition and anemia on accuracy of a real-time continuous glucose monitor in diabetes patients on continuous ambulatory peritoneal dialysis","volume":"26","author":"Ling","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1507\/endocrj.EJ17-0356","article-title":"Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes","volume":"65","author":"Kurosawa","year":"2018","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2025.05.749_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2022.04.007","article-title":"Glucose profiles in obstructive sleep apnea and type 2 diabetes mellitus","volume":"95","author":"Aurora","year":"2022","journal-title":"Sleep Med"},{"key":"10.1016\/j.eprac.2025.05.749_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40842-020-00098-0","article-title":"A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system","volume":"6","author":"Khaire","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.148","article-title":"Effect of 12-week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial","volume":"4","author":"Bangh\u00f8j","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib53","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5664\/jcsm.27347","article-title":"CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep","volume":"4","author":"Dawson","year":"2008","journal-title":"J Clin Sleep Med"},{"issue":"17","key":"10.1016\/j.eprac.2025.05.749_bib54","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.4103\/0366-6999.163382","article-title":"Effect of continuous positive airway pressure therapy on glycemic excursions and insulin sensitivity in patients with obstructive sleep apnea-hypopnea syndrome and type 2 diabetes","volume":"128","author":"Guo","year":"2015","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archinte.165.4.447","article-title":"Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea","volume":"165","author":"Babu","year":"2005","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2025.05.749_bib56","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1089\/15209150050214168","article-title":"Continuous glucose monitoring system: a new approach to the diagnosis of diabetic gastroparesis","volume":"2","author":"Tanenberg","year":"2000","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"10.1016\/j.eprac.2025.05.749_bib57","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1007\/s10620-011-1810-z","article-title":"Continuous glucose monitoring in gastroparesis","volume":"56","author":"Ramzan","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.749_bib58","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1177\/19322968211015206","article-title":"Classification of gastroparesis from glycemic variability in type 1 diabetes: a proof-of-concept study","volume":"16","author":"Cichosz","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194759","article-title":"Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: an open-label pilot prospective study","volume":"13","author":"Calles-Escand\u00f3n","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.eprac.2025.05.749_bib60","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/dia.2019.0254","article-title":"Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis","volume":"21","author":"Kaur","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2025.05.749_bib61","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/dom.15096","article-title":"Continuous glucose monitoring in patients with post-bariatric hypoglycaemia reduces hypoglycaemia and glycaemic variability","volume":"25","author":"Cummings","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.749_bib62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4093\/dmj.2021.0164","article-title":"Glucose profiles assessed by intermittently scanned continuous glucose monitoring system during the perioperative period of metabolic surgery","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib63","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s11695-018-03684-5","article-title":"Continuous glucose monitoring in bariatric patients undergoing laparoscopic sleeve gastrectomy and laparoscopic roux-en-Y gastric bypass","volume":"29","author":"Wysocki","year":"2019","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.eprac.2025.05.749_bib64","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.numecd.2020.06.029","article-title":"Continuous glucose monitoring in subjects undergoing bariatric surgery: diurnal and nocturnal glycemic patterns","volume":"30","author":"Lupoli","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.eprac.2025.05.749_bib65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.soard.2023.07.008","article-title":"Glycemic variability and hypoglycemia before and after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy - a cohort study of females without diabetes","volume":"20","author":"Nilsen","year":"2024","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"10.1016\/j.eprac.2025.05.749_bib66","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s11695-019-03826-3","article-title":"Comparison of meal pattern and postprandial glucose response in duodenal switch and gastric bypass patients","volume":"29","author":"Nilsen","year":"2019","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.eprac.2025.05.749_bib67","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.soard.2014.11.003","article-title":"Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test","volume":"11","author":"Kefurt","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101255","article-title":"Early continuous glucose monitoring for predicting remission of type 2 diabetes 1 year after bariatric surgery","volume":"47","author":"Turquetil","year":"2021","journal-title":"Diabetes Metab"},{"issue":"10","key":"10.1016\/j.eprac.2025.05.749_bib69","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/dom.14783","article-title":"Forecasting postbariatric hypoglycaemia in patients after Roux-en-Y gastric bypass using model-based algorithms fed by continuous glucose monitoring data: a proof-of-concept study","volume":"24","author":"Prendin","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/dia.2017.0298","article-title":"Design and clinical evaluation of a novel low-glucose prediction algorithm with mini-dose stable glucagon delivery in post-bariatric hypoglycemia","volume":"20","author":"Laguna Sanz","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib71","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1210\/clinem\/dgz197","article-title":"A randomized, placebo-controlled double-blind trial of a closed-loop glucagon system for postbariatric hypoglycemia","volume":"105","author":"Mulla","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.05.749_bib72","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.3390\/curroncol31090403","article-title":"Insulinoma unmasked: a continuous glucose monitoring-fueled journey","volume":"31","author":"Koceva","year":"2024","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1016\/j.eprac.2025.05.749_bib73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/ERC-20-0447","article-title":"CGM for insulinoma screening: a prospective and observational case-control study","volume":"28","author":"Ma","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.eprac.2025.05.749_bib74","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPA.0000000000001735","article-title":"Continuous glucose monitoring in patients with insulinoma treated by endoscopic ultrasound-guided ethanol injection","volume":"50","author":"Yuan","year":"2021","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.eprac.2025.05.749_bib75","first-page":"623","article-title":"Characteristics of 72 h glucose profiles detected by continuous glucose monitoring system in patients with insulinoma","volume":"45","author":"Hua","year":"2014","journal-title":"J Sichuan Univ (Medical Sciences)"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cen.13961","article-title":"Medical therapy in patients with endogenous hypoglycaemia: is euglycaemia achievable?","volume":"90","author":"Vezzosi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2025.05.749_bib77","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-024-02472-6","article-title":"Intraoperative intermittently scanned continuous glucose monitoring in the management of patients with pancreatic insulinoma","author":"Magliozzo","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.eprac.2025.05.749_bib78","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2265.2007.03161.x","article-title":"Continuous glucose monitoring in patients with insulinoma","volume":"68","author":"Munir","year":"2008","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T19:07:14Z","timestamp":1756753634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1530891X25009012"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.749","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.05.749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}